University Hospitals Birmingham NHS Foundation Trust

Reports

Status Drug name NICE TAs Comments
Status: Amber Roflumilast (Daxas)

To be use in line with NICE. Supported with a RICaD

Status: Amber Ropinirole M/R tablets

ESCA for Parkinson's disease

Status: Amber Ropinirole tablets

ESCA for restless legs

Status: Amber Rotigotine patches

Specialist initiation and stabilisation, ESCA

Status: Green Rubber contraceptive diaphragms - Type A Diaphragm with Flat Metal Spring

Flat spring diaphragm sizes 55–95mm (rising in 5mm)

Status: Amber Rufinamide tablets

ESCA

Status: Amber Sacubitril/Valsartan (Entresto®)

RICaD. Transfer to primary care at three months following initiation by Heart Failure specialist supported by a RICaD.

Status: Red Salicylic acid 10% w/w in emulsifying ointment

Unlicensed special

Status: Red Salicylic acid 2% w/w and sulphur 2% w/w in aqueous cream

Unlicensed special

Status: Red Salicylic acid 2% w/w in emulsifying ointment

Unlicensed special

Drug status key

Formulary drugs are allocated a traffic light status. This provides guidance on where clinical and prescribing responsibilities lie in regard to the initiation and maintenance of prescribing.

Grey

Grey

Positive NICE TA and/or awaiting local clarification on place in therapy. Please contact your medicines optimisation team for more information.

Red

Red

Initiation and maintenance of prescribing by specialists only.

Amber

Amber

Initiation and maintenance of prescribing by specialists and transfer to primary care prescribing when appropriate, or in primary care following a specialists recommendation. Prior to initiation some medicines may require committee agreement or a framework to support safe transfer and maintenance.

Green

Green

Initiation and maintenance of prescribing by specialists, GPs and other qualified clinicians.

Blue

Blue

Under review at University Hospitals Birmingham NHS Foundation Trust.

Building healthier lives
Back to top